Catalyst Pharmaceuticals, Inc. (CPRX)

NASDAQ: CPRX · Real-Time Price · USD

23.53

+0.45 (1.95%)

At close: Dec 5, 2025, 4:00 PM EST

23.77

+0.24 (1.04%)

After-hours: Dec 5, 2025, 7:59 PM EST

Catalyst Pharmaceuticals Market Cap

Catalyst Pharmaceuticals has a market cap or net worth of $2.89 billion as of December 5, 2025. Its market cap has increased by 13.36% in one year.

Market Cap

2.89B

Enterprise Value

2.21B

1-Year Change

13.36%

Ranking

#1752

Market Cap Chart

Since December 15, 2006, Catalyst Pharmaceuticals's market cap has increased from $69.00M to $2.89B, an increase of 4,091.49%. That is a compound annual growth rate of 21.74%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	2.89B	16.19%
Dec 31, 2024	2.49B	38.90%
Dec 29, 2023	1.79B	-7.42%
Dec 30, 2022	1.94B	177.28%
Dec 31, 2021	698.10M	101.65%
Dec 31, 2020	346.20M	-10.40%
Dec 31, 2019	386.40M	95.84%
Dec 31, 2018	197.30M	-40.80%
Dec 29, 2017	333.30M	283.10%
Dec 30, 2016	87.00M	-57.12%
Dec 31, 2015	202.90M	-1.17%
Dec 31, 2014	205.30M	94.41%
Dec 31, 2013	105.60M	599.34%
Dec 31, 2012	15.10M	-52.66%
Dec 30, 2011	31.90M	66.15%
Dec 31, 2010	19.20M	68.42%
Dec 31, 2009	11.40M	-54.94%
Dec 31, 2008	25.30M	-41.44%
Dec 31, 2007	43.20M	-28.60%
Dec 29, 2006	60.50M	-12.32%

View and export this data all the way back to 2006. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	904.62B
Johnson & Johnson	486.51B
AbbVie	399.57B
UnitedHealth Group	299.75B
AstraZeneca	280.82B
Novartis AG	255.15B
Merck & Co.	247.51B
Abbott Laboratories	217.50B

Market Cap Rankings